Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Caren Deardorf currently holds 9,730 shares of Crinetics Pharmaceuticals, Inc. (CRNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Caren Deardorf has been a net seller of CRNX stock. They have purchased $0 and sold $42.0K worth of shares.
Caren Deardorf's most recent insider trade was on Jun 18, 2026, when they sold 9,730 shares at $0.00 per share.
Caren Deardorf serves as Executive at Crinetics Pharmaceuticals, Inc. (CRNX). They have executed 9 insider transactions totaling $42.0K over their tenure at the company.
Caren Deardorf holds the position of Executive at Crinetics Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Caren Deardorf has shown a selling trading pattern, with $0 in total purchases and $42.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Caren Deardorf was on Sep 16, 2021, when they sold $42.0K worth of MGTA shares. This transaction involved 6,238 shares at $6.73 per share.
Caren Deardorf currently owns 9,730 shares of Crinetics Pharmaceuticals, Inc. (CRNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Caren Deardorf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Caren Deardorf has 9 Form 4 filings on record as an insider at Crinetics Pharmaceuticals, Inc..
Set alerts for Caren Deardorf and 40,000+ other insiders.